Amikam, U.; Hochberg, A.; Shenhav, M.; Haj, L.; Hochberg-Klein, S.; Hiersch, L.; Yogev, Y.
Anti-Phospholipid Antibodies in Women with Placenta-Mediated Complications Delivered at >34 Weeks of Gestation. J. Clin. Med. 2023, 12, 4516.
https://doi.org/10.3390/jcm12134516
AMA Style
Amikam U, Hochberg A, Shenhav M, Haj L, Hochberg-Klein S, Hiersch L, Yogev Y.
Anti-Phospholipid Antibodies in Women with Placenta-Mediated Complications Delivered at >34 Weeks of Gestation. Journal of Clinical Medicine. 2023; 12(13):4516.
https://doi.org/10.3390/jcm12134516
Chicago/Turabian Style
Amikam, Uri, Alyssa Hochberg, Michael Shenhav, Lilian Haj, Sarit Hochberg-Klein, Liran Hiersch, and Yariv Yogev.
2023. "Anti-Phospholipid Antibodies in Women with Placenta-Mediated Complications Delivered at >34 Weeks of Gestation" Journal of Clinical Medicine 12, no. 13: 4516.
https://doi.org/10.3390/jcm12134516
APA Style
Amikam, U., Hochberg, A., Shenhav, M., Haj, L., Hochberg-Klein, S., Hiersch, L., & Yogev, Y.
(2023). Anti-Phospholipid Antibodies in Women with Placenta-Mediated Complications Delivered at >34 Weeks of Gestation. Journal of Clinical Medicine, 12(13), 4516.
https://doi.org/10.3390/jcm12134516
